Supplier News

CAS Awarded Patents for Cerebral Oximeter Technology

CAS Medical Systems Inc., a Branford, CT-based medical device company focused on innovative non-invasive vital signs monitoring, announced that it has been awarded two US Patents for technology used in its FORE-SIGHT Cerebral Oximeter, which is scheduled for commercial release in late 2006.
    According to a company press release, the patents represent several years of research and development focused on bringing to market a non-invasive, commercially viable technology that allows clinicians to monitor absolute levels of oxygen saturation in the brain.
    “Our research and development team has made great strides in the development of this device, and the receipt of two more patents for technology used in FORE-SIGHT is an important milestone and highlights our strong IP position,” stated President and CEO of CAS Medical, Louis P. Scheps. “Our goal is to continue to pursue the issuance of patents to enable us to maximize the value of the innovative technology used in this compelling device. We believe that our recent achievements, in combination with the launch of the FORE-SIGHT product at the end of this year, will continue to propel the company’s future growth,” he added.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters